Denifanstat, a Fatty Acid Synthase Inhibitor, Increased Circulating Polyunsaturated Triglycerides and Decreased LDL-Cholesterol in MASH Patients with Advanced Fibrosis
Keystone Symposia
8th Annual MASH Drug Development Summit
7th Obesity and NASH Drug Development Summit